In humans, a higher level of MMP2 expression is reported in myxomatous valves compared to normal valves, and recognition of a mediating role for MMP2 in the pathogenesis of MVP may have practical implications [37,38]. The gene discussed is MMP2; the disease is familial mitral valve prolapse.